on Carl Zeiss Meditec AG (ETR:AFX)
Leadership Changes Announced at Carl Zeiss Meditec AG
Carl Zeiss Meditec AG has announced the termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 due to a breach of the ZEISS Group’s Code of Conduct. This decision, mutually agreed upon, was sparked by a conflict of interest linked to internal interactions. Importantly, this issue does not impact the company's business activities.
In response, Andreas Pecher will step in as interim CEO starting 1 January 2026. Pecher, currently CEO of Carl Zeiss AG, will resign from his position as Chairman of the Supervisory Board, which will then be temporarily led by Peter Kameritsch. Meanwhile, Carl Zeiss Meditec AG's strategic direction is set to continue without interruption.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Carl Zeiss Meditec AG news